Related references
Note: Only part of the references are listed.Global colorectal cancer burden in 2020 and projections to 2040
Yue Xi et al.
TRANSLATIONAL ONCOLOGY (2021)
A three-phase trans-ethnic study reveals B7-H3 expression is a significant and independent biomarker associated with colon cancer overall survival
Yuan Gao et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers
Xing Liu et al.
ONCOTARGETS AND THERAPY (2021)
Comparison of guidelines on rectal cancer: exception proves the rule?
Ruoxu Dou et al.
GASTROENTEROLOGY REPORT (2021)
High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer
Dong Won Baek et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population
Ihsane El Otmani et al.
DISEASE MARKERS (2020)
Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients
Vincent Ho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini et al.
PHARMACOLOGY & THERAPEUTICS (2020)
53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer
Ai Huang et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2020)
PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production
Yujing Tan et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Potential Therapeutic Targets of B7 Family in Colorectal Cancer
Changgang Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of gut microbiota in cancer treatment: friend or foe?
Wing Yin Cheng et al.
GUT (2020)
Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patients
Kazuaki Yasui et al.
JOURNAL OF RADIATION RESEARCH (2020)
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Winnie Fong et al.
ONCOGENE (2020)
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer
Y. Nancy You et al.
DISEASES OF THE COLON & RECTUM (2020)
Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Yiyi Zhang et al.
ONCOTARGETS AND THERAPY (2020)
Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer
Jason K. Douglas et al.
MOLECULAR & CELLULAR ONCOLOGY (2020)
Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Xuezhi Zhou et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
FOXK transcription factors: Regulation and critical role in cancer
Ying Liu et al.
CANCER LETTERS (2019)
Vanin 1: Its Physiological Function and Role in Diseases
Roberta Bartucci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Roles And Signaling Pathways Of Phosphatidylethanolamine-Binding Protein 4 In Tumors
Zi-Kang Luo et al.
ONCOTARGETS AND THERAPY (2019)
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer
Felix Harpain et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma
Edoardo D'Angelo et al.
JOURNAL OF CLINICAL PATHOLOGY (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma
Ziwen Zhu et al.
ONCOTARGETS AND THERAPY (2018)
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Vincent Ho et al.
BMC CANCER (2018)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery
Jianhong Peng et al.
TUMOR BIOLOGY (2017)
New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network
Kecheng Zhou et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2017)
TAMeless traitors: macrophages in cancer progression and metastasis
Shweta Aras et al.
BRITISH JOURNAL OF CANCER (2017)
Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
Eisar Al-Sukhni et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy
Susumu Saigusa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion
Nils Halberg et al.
CANCER CELL (2016)
Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma
Damiano Caputo et al.
CANCER INVESTIGATION (2016)
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
Teresa Gomez del Pulgar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Distance to the Anal Verge Is Associated With Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Sunil V. Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Arancha Cebrian et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Effect of a chemical inhibitor of human phosphatidylethanolamine-binding protein 4 on radiosensitivity of rectal cancer cells
Jianming Qiu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2016)
GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer
Kunli Zhu et al.
ONCOTARGET (2016)
Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma
Haihua Peng et al.
ONCOTARGET (2016)
Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy
Jeong Il Yu et al.
ONCOTARGET (2016)
Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer
Mohamed A. Ahmed et al.
ONCOTARGET (2016)
Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response
Rong Yan et al.
ONCOTARGET (2016)
MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response
Vincent Ho et al.
PLOS ONE (2016)
NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival
R. Voboril et al.
NEOPLASMA (2016)
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer
Cristina Carames et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Special AT-rich sequence binding protein 1 expression correlates with response to preoperative radiotherapy and clinical outcome in rectal cancer
Wen-Jian Meng et al.
CANCER BIOLOGY & THERAPY (2015)
Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma
Aziz Zaanan et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer
Cristina Carames et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2015)
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy
Ying-En Lee et al.
TUMOR BIOLOGY (2015)
Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer
Yan-Ta Guo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy
Chang-Jiang Qin et al.
ONCOTARGET (2015)
Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer
Jacopo Martellucci et al.
UPDATES IN SURGERY-ITALY (2015)
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
Vibeke A. Ingebrigtsen et al.
BMC CANCER (2014)
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
Camila Miranda Lopes-Ramos et al.
BMC MEDICAL GENOMICS (2014)
Gene expression profile is associated with chemoradiation resistance in rectal cancer
G. A. Gantt et al.
COLORECTAL DISEASE (2014)
Can a Biomarker-Based Scoring System Predict Pathologic Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer?
Hyuk Hur et al.
DISEASES OF THE COLON & RECTUM (2014)
Proliferating cell unclear antigen-associated factor (PAF15): A novel oncogene
Chanlu Xie et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
An Oncogenic Protein Golgi Phosphoprotein 3 Up-regulates Cell Migration via Sialylation
Tomoya Isaji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
Zaozao Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Changes in the plasma levels of cytokines/chemokines for predicting the response to chemoradiation therapy in rectal cancer patients
Noriko Tada et al.
ONCOLOGY REPORTS (2014)
Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer
Jeroen Buijsen et al.
RADIOTHERAPY AND ONCOLOGY (2014)
XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor
Kaiwu Xu et al.
ONCOLOGY LETTERS (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
THE EFFECT OF TRANSVERSUS ABDOMINUS PLANE BLOCKS ON POSTOPERATIVE PAIN IN LAPAROSCOPIC COLORECTAL SURGERY: A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL.
D. Keller et al.
DISEASES OF THE COLON & RECTUM (2014)
Mutations in Specific Codons of the KRAS Oncogene are Associated with Variable Resistance to Neoadjuvant Chemoradiation Therapy in Patients with Rectal Adenocarcinoma
Marjun P. Duldulao et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?
Brian D. Cholewa et al.
CANCER RESEARCH (2013)
miRNA profiling of cancer
Gianpiero Di Leva et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2013)
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma
Pierre Tennstedt et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy
Jianming Qiu et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?
Lian-Ming Wu et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
MRI Predictive Factors for Tumor Response in Rectal Cancer Following Neoadjuvant Chemoradiation Therapy - Implications for Induction Chemotherapy?
Stanley K. T. Yu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Tumour heterogeneity in the clinic
Philippe L. Bedard et al.
NATURE (2013)
B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells
Sheng-Jia Shi et al.
PLOS ONE (2013)
microRNA expression is able to predict response to chemoradiotherapy in rectal cancer
Masanori Hotchi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Celebrating 25 years of NF-κB research
Sankar Ghosh et al.
IMMUNOLOGICAL REVIEWS (2012)
Correlation of SATB1 overexpression with the progression of human rectal cancer
Wen-Jian Meng et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2012)
PET-BASED TREATMENT RESPONSE EVALUATION IN RECTAL CANCER: PREDICTION AND VALIDATION
Marco H. M. Janssen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Marek Svoboda et al.
RADIATION ONCOLOGY (2012)
Prediction in Rectal Cancer
Eliane C. M. Zeestraten et al.
SEMINARS IN RADIATION ONCOLOGY (2012)
Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer
Julio Garcia-Aguilar et al.
ANNALS OF SURGERY (2011)
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
Koji Yasuda et al.
RADIATION ONCOLOGY (2011)
The expression of PEBP4 protein in lung squamous cell carcinoma
Gui-Ping Yu et al.
TUMOR BIOLOGY (2011)
KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy
Jochen Gaedcke et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Ye-Rang Yun et al.
Journal of Tissue Engineering (2010)
MOLECULAR GENETIC CHANGES ASSOCIATED WITH COLORECTAL CARCINOGENESIS ARE NOT PROGNOSTIC FOR TUMOR REGRESSION FOLLOWING PREOPERATIVE CHEMORADIATION OF RECTAL CARCINOMA
N. Peter Zauber et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Development of the 21-gene assay and its application in clinical practice and clinical trials
Joseph A. Sparano et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy
Anne Y. Lin et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients
Eva Angenete et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
p53 in health and disease
Karen H. Vousden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer
M Gavioli et al.
DISEASES OF THE COLON & RECTUM (2005)
P53 status and response to radiotherapy in rectal cancer:: a prospective multilevel analysis
E Lopez-Crapez et al.
BRITISH JOURNAL OF CANCER (2005)
Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy
BM Ghadimi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Response to neoadjuvant therapy for rectal cancer: influence on long-term results
S Biondo et al.
COLORECTAL DISEASE (2005)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prognostic value of p53 mutations in rectal carcinoma
C Rebischung et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
TP53 genotype but not p53 immunohistochemical result predicts response to Preoperative short-term radiotherapy in rectal cancer
D Kandioler et al.
ANNALS OF SURGERY (2002)
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients
SP Hiotis et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2002)
Structure and function of 17β-hydroxysteroid dehydrogenase type 1 and type 2
P Vihko et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Share Paper
